Browsing Category

Top Industry News

7456 posts

Pfizer Wins Bidding War for Obesity Drug Specialist Metsera
By

By
Pfizer has won its bidding war with Novo Nordisk for Metsera, a New York-based clinical-stage bio/pharmaceutical company focused on obesity and cardiometabolic diseases, with a successful offer, worth up to…

FDA Names New Head of CDER 
By

By
Richard Pazdur, M.D., currently Director of the Oncology Center of Excellence at the US Food and Drug Administration (FDA), has been named the new Director of the Center of Drug…

Novartis Opens New Radioligand Therapy Mfg Facility in the US 
By

By
Novartis has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. The facility is part of the company’s previously announced planned $23-billion investment over five years in…

Mallinckrodt, Endo Launch as Keenova Therapeutics Following Merger Close; Spin Off Par Health 
By

By
Mallinckrodt and Endo, two specialty pharma and generics companies, have announced the next step in their merger plan, first announced in March 2025, and completed on August 1, 2025. The…

Supplier News: Bachem, Curia, Abzena, Avid & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Bachem, Curia, MilliporeSigma, Abzena, Argonaut Manufacturing Servies, BioDuro, Avid Bioservices, and UPS.   Chemicals/Chemical API Manufacturing * Curia Completes $4-M Investment To Upgrade API…

Global Briefs: AstraZeneca, Lilly, SanegeneBio & More 
By

By
A roundup of news from AstraZeneca/SixPeaks, Eli Lilly and Company/SanegeneBio,and Eli Lilly and Company/MeiraGTx. Highlights below.   M&A News * AstraZeneca Completes Acquisition of Obesity Drug Specialists SixPeaks Partnering News * Lilly, SanegeneBio in…

Kimberly-Clark to Acquire Kenvue for $48.7 Bn 
By

By
Kimberly-Clark Corporation, a consumer products company, has agreed to acquire Kenvue, the former consumer products and over-the-counter (OTC) healthcare business of Johnson & Johnson (J&J) and now an independent company, for $48.7 billion.   The acquisition of Kenvue comes approximately two years after J&J completed its move to demerge its…

Lilly to Build $3-Bn Oral Drug Mfg Facility in EU 
By

By
Eli Lilly and Company has announced plans to build a new $3-billion manufacturing facility in Katwijk, the Netherlands, to expand Lilly’s capacity to produce oral solid  medicines in cardiometabolic health, neuroscience, oncology, and immunology …

Pfizer, Novo Nordisk Battle for Obesity Drug Specialist Metsera
By

By
Pfizer issued a statement this week (November 5, 2025) in response to the Delaware Chancery Court’s decision denying Pfizer’s request for a temporary restraining order to prevent Metsera, a New York-based…

Sandoz to Acquire Just – Evotec Biologics EU Mfg Site in $650-M Deal 
By

By
In a move to boost manufacturing capacity for its biosimilars portfolio, Sandoz has agreed to acquire Just-Evotec Biologics EU SAS (JEB SAS), which includes a continuous biomanufacturing site in Toulouse, France, in a deal worth up to $650 million ($350 million…